Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seminomatous Germ Cell Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02375204
What this trial is testing

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Who this might be right for
Germ Cell TumorTeratomaChoriocarcinoma+8 more
Alliance for Clinical Trials in Oncology 420
Testing effectiveness (Phase 2)UnknownNCT02797626
What this trial is testing

Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)

Who this might be right for
Stage II A/B Seminomatous Germ Cell Tumors
Heinrich-Heine University, Duesseldorf 30
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Testing effectiveness (Phase 2)Study completedNCT00070096
What this trial is testing

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT02034110
What this trial is testing

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Who this might be right for
Cancer
Novartis Pharmaceuticals 206
Testing effectiveness (Phase 2)Study completedNCT00470366
What this trial is testing

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT02317393
What this trial is testing

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

Who this might be right for
Non-seminomatous Germ Cell TumorsMetastasis
Centre Francois Baclesse 16
Not applicableStudy completedNCT00045045
What this trial is testing

Positron Emission Tomography in Detecting Testicle Cancer

Who this might be right for
Testicular Germ Cell Tumor
Institute of Cancer Research, United Kingdom
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Looking for participantsNCT06418789
What this trial is testing

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

Who this might be right for
Germ Cell Tumor
N.N. Petrov National Medical Research Center of Oncology 25
Early research (Phase 1)Looking for participantsNCT07218913
What this trial is testing

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Who this might be right for
Hearing LossMetastatic Malignant Germ Cell TumorMetastatic Malignant Nongerminomatous Germ Cell Tumor+4 more
City of Hope Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT00453232
What this trial is testing

Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTeratomaTesticular Germ Cell Tumor
Cambridge University Hospitals NHS Foundation Trust 20
Testing effectiveness (Phase 2)Study completedNCT00423852
What this trial is testing

Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04876456
What this trial is testing

A Phase II Trial of Cabozantinib With Patients With Refractory GCTs

Who this might be right for
Germ Cell TumorSeminomaNon-seminomatous Germ Cell Tumor+1 more
Jennifer King 50
Testing effectiveness (Phase 2)UnknownNCT00551122
What this trial is testing

Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more
University of Southampton 23
Testing effectiveness (Phase 2)UnknownNCT01172912
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorTesticular Germ Cell Tumor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 47
Not applicableLooking for participantsNCT05705687
What this trial is testing

Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors

Who this might be right for
Non-Seminomatous Germ Cell Tumor
Gustave Roussy, Cancer Campus, Grand Paris 150
Large-scale testing (Phase 3)Study completedNCT00104676
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTeratomaTesticular Germ Cell Tumor
UNICANCER 263
Large-scale testing (Phase 3)UnknownNCT00003643
What this trial is testing

Combination Chemotherapy in Treating Men With Germ Cell Cancer

Who this might be right for
Extragonadal Germ Cell TumorTeratomaTesticular Germ Cell Tumor
European Organisation for Research and Treatment of Cancer - EORTC 498